Publications
716
Citations
35,182
Est. group size
~4
Recurring co-author estimate
Active years
22
Publishing since 2005
Liana G. Apostolova studies Alzheimer's disease and related forms of dementia, with a strong focus on brain imaging (such as amyloid and tau PET scans) and biomarkers used to detect and stage the disease. The work spans clinical trials of new drug treatments (for example, donanemab and lecanemab), genetic risk factors, and how brain inflammation and protein buildup relate to cognitive decline, including early-onset cases.
Publication activity has remained high and steady over the past decade, averaging roughly 34 papers per year with a notable peak in 2023.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- The Indiana University Brain Health Program to deliver amyloid‐targeted therapy to Alzheimer's disease patients
Alzheimer s & Dementia Translational Research & Clinical Interventions · 2026
- Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease
Genome biology · 2025
- Donanemab: Appropriate use recommendations
The Journal of Prevention of Alzheimer s Disease · 2025
- Clinical criteria for limbic‐predominant age‐related TDP‐43 encephalopathy
Alzheimer s & Dementia · 2025
- Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity
JAMA · 2025
- Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Nature Reviews Neurology · 2024
- Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway
Nature Neuroscience · 2024
- Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer’s disease
Brain · 2024
- Promoting Growth in Behavioral Neurology: A Path Forward
Cognitive and Behavioral Neurology · 2024
- 1978 Donanemab in early symptomatic Alzheimer’s Disease: Efficacy and safety in TRAILBLAZER-ALZ 2, Phase 3 Randomized Clinical Trial
Age and Ageing · 2024
- Neuroinflammation Co-localizes Highly with Tau in Mild Cognitive Impairment from Early Onset Alzheimer’s Disease (N4.002)
Neurology · 2024
- Reproducibility of Centiloid Values in Real‐World Amyloid PET Data: Comparison of the Imaging Dementia‐Evidence for Amyloid Scanning (IDEAS) to Four Large Research Datasets
Alzheimer s & Dementia · 2024
- A clock model of regional tau‐PET accumulation and cognitive decline in sporadic early‐onset Alzheimer's disease
Alzheimer s & Dementia · 2024
- Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics
Brain · 2023
- TAF15 amyloid filaments in frontotemporal lobar degeneration
Nature · 2023
- Alzheimer s & Dementia×230
- Neurology×15
- Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring×12
- PMC×11
- medRxiv×10
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile